Related Experiment Video
Updated: Dec 3, 2025
10:36
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
12.4K
Expanding detection windows for discriminating single nucleotide variants using rationally designed DNA equalizer
Guan A Wang1,2, Xiaoyu Xie2, Hayam Mansour2,3
1Key Laboratory of Green Chemistry & Technology of Ministry of Education, College of Chemistry, Sichuan University, 610064, Chengdu, Sichuan, China.
Nature Communications
|October 30, 2020
Summary
We developed a DNA equalizer gate (DEG) approach to improve nucleic acid probe performance for detecting genetic variations. This simulation-guided method expands detection windows and enhances sequence selectivity in double-stranded DNA (dsDNA).
Area of Science:
- Molecular Biology
- Biotechnology
- Nanotechnology
Background:
- Nucleic acid hybridization probes are crucial for DNA nanotechnology and biomedical applications.
- Current methods face limitations in detecting single nucleotide variants in double-stranded DNA (dsDNA).
Purpose of the Study:
- To introduce a novel simulation-guided nucleic acid probe, the DNA equalizer gate (DEG) approach.
- To expand detection windows and improve sequence selectivity for single nucleotide variant discrimination in dsDNA.
Main Methods:
- Developed a DNA equalizer gate (DEG) approach using simulation-guided design.
- Created a thermodynamic-driven theoretical model to predict DEG performance.
- Validated DEG effectiveness through in silico and experimental studies.
Main Results:
- DEG approach significantly expands detection windows for single nucleotide variant discrimination.
- Demonstrated enhanced sequence selectivity in dsDNA analysis.
- Showcased adaptability to nucleic acid amplification techniques like PCR.
Conclusions:
- The DEG approach offers a powerful tool for designing and operating nucleic acid probes.
- DEG effectively expands detection windows and improves sequence selectivity.
- Practical applications demonstrated in simultaneous detection of infections and drug-resistance screening.
